MAP2K7 and thyroid gland undifferentiated (anaplastic) carcinoma: BI-847325, a selective dual MEK and Aurora kinases inhibitor, reduces aggressive behavior of anaplastic thyroid carcinoma on an in vitro three-dimensional culture